Back to Search
DANA MUNN, PHARMD
PHARMD
Pharmacist
NPI: 1285041954Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
059359(NY)
Research & Publications (20)
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.
PMID 19366986·Blood·2009
7-preclinical
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
PMID 19465693·Blood·2009
8-other
IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.
PMID 19218483·J Leukoc Biol·2009
7-preclinical
IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.
PMID 19635913·J Immunol·2009
4-observational
Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice.
PMID 19414747·J Immunol·2009
7-preclinical
Creating immune privilege: active local suppression that benefits friends, but protects foes.
PMID 18064049·Nat Rev Immunol·2008
6-review
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality.
PMID 18077788·Blood·2008
7-preclinical
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
PMID 18952840·Proc Natl Acad Sci U S A·2008
7-preclinical
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation.
PMID 18436652·Proc Natl Acad Sci U S A·2008
7-preclinical
Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.
PMID 18522536·Biochem J·2008
7-preclinical
The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.
PMID 18832696·J Immunol·2008
8-other
Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption.
PMID 17868966·Food Chem Toxicol·2008
7-preclinical
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
PMID 18026137·Oncogene·2008
7-preclinical
HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.
PMID 18776940·J Clin Invest·2008
8-other
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
PMID 17710230·J Clin Invest·2007
7-preclinical
The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse.
PMID 17911589·J Immunol·2007
7-preclinical
Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.
PMID 18377355·Expert Rev Vaccines·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8061 BREWERTON RD
CICERO, NY 13039 - Phone
- (315) 698-2381
Quick Facts
- NPI
- 1285041954
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile